AlgoRx and Corgentech to Webcast Presentation From the Lazard Capital Markets 2005 Life Sciences Conference
22 Novembre 2005 - 1:00PM
PR Newswire (US)
SECAUCUS, N.J. and SOUTH SAN FRANCISCO, Calif., Nov. 22
/PRNewswire-FirstCall/ -- AlgoRx Pharmaceuticals, Inc. and
Corgentech Inc. (NASDAQ:CGTK), today announced that John P.
McLaughlin, Corgentech's chief executive officer, will present at
the Lazard Capital Markets 2005 Life Sciences Conference on
November 30, 2005 at 11:00 a.m. EST in New York, NY. To access the
live webcast or the subsequent archived recording, log on to
http://www.corgentech.com/ and go to the Investors page, and click
on Webcasts. Please connect to Corgentech's website several minutes
prior to the start of the webcast to ensure adequate time for any
software download that may be necessary. Corgentech and private
company, AlgoRx Pharmaceuticals, Inc., recently announced that they
have signed a definitive agreement to merge and create a late-stage
company that will be focused on developing and commercializing
products for pain management and inflammation. About AlgoRx AlgoRx
is a private, emerging pharmaceutical company focused on developing
and commercializing a diversified portfolio of pharmaceutical
product candidates to address pain, a large and under-served
market. AlgoRx's portfolio of pain management drug candidates
includes ALGRX 3268, which has completed Phase 3 clinical trials,
ALGRX 4975, which is in Phase 2 clinical trials, and ALGRX 1207,
which is soon to enter the clinic. AlgoRx is based in Secaucus, NJ.
For more information on the company and its technologies, please
visit http://www.algorx.com/. About Corgentech Corgentech is a
biopharmaceutical company focused on the development and
commercialization of novel therapeutics for significant unmet
medical needs. Corgentech is based in South San Francisco, CA. For
more information on the company and its technologies, please visit
http://www.corgentech.com/. DATASOURCE: Corgentech CONTACT:
Jennifer Cook Williams, Senior Director, Investor Relations of
Corgentech Inc., +1-650-624-9600, or Web site:
http://www.corgentech.com/
Copyright
Corgentech (NASDAQ:CGTK)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Corgentech (NASDAQ:CGTK)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Corgentech Inc. (MM) (NASDAQ): 0 recent articles
Plus d'articles sur Corgentech Inc. (MM)